AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

CLGN · NASDAQ · Biotechnology

CollPlant Biotechnologies (ADR)

Produces plant-derived recombinant human collagen for bioinks, regenerative products, and aesthetics development.

$0.3240

Pre-market−0.06 (−16.49%)

At close$0.3880(+8.38%)

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions1 holder · as of Mar 31, 2026	0.00%	71 ADS
Insiders4 holders · as of Apr 27, 2026	15.63%	2.00M ADS
Strategic holders1 holder · as of Feb 24, 2022	1.59%	204.0K ADS
Otherremainder	82.78%	10.60M ADS

12.80M ADS as of Sep 1, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Ami SagyInsider	12.79%	1.64M	13Dfiled Nov 28, 2025 ↗
Hugh M. EvansInsiderdirector	2.58%	330,554 ordinary	Form 4filed Apr 27, 2026 ↗
The Upper Ground Tater TrustStrategic	1.59%	204,000	13G/Afiled Feb 24, 2022 ↗
Yehiel TalInsiderdirector, officer: Chief Executive Officer	0.24%	31,137 ordinary	Form 4filed Mar 19, 2026 ↗
Philippe BensimonInsiderofficer: VP Regulations and QA	0.02%	2,000 ordinary	Form 4filed Mar 18, 2026 ↗
Parallel Advisors, LLCInstitution	0.00%	71 ADS	13Fas of Mar 31, 2026
Ami SagiInsider	—16.40% of class, as filed	—	13Gfiled May 18, 2018 ↗
JKALL Holdings, LLCStrategic	—7.80% of class, as filed	—	13Gfiled Sep 16, 2019 ↗
Meitav Dash Investments Ltd.Strategic	—5.52% of class, as filed	—	13D/Gfiled Feb 2, 2022 ↗
Roumell Asset Management, LLC ("RAM")Institution	—5.50% of class, as filed	—	13D/Gfiled Feb 13, 2023 ↗
Strata Trust Company Custodian FBO George Walter Loewenbaum IRAStrategic	—7.80% of class, as filed	—	13Gfiled Sep 18, 2019 ↗
The Loewenbaum 1992 TrustStrategic	—17.50% of class, as filed	—	13Dfiled Aug 21, 2026 ↗

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

1 holder · 71 shares · 0 new positions · 0 increased · 1 reduced · 0 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Parallel Advisors, LLC	71	0.00%	−3.2K	Jun 3, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
The Loewenbaum 1992 Trustincl. Elizabeth S. Loewenbaum, George Walter Loewenbaum +4 more	17.50%	3.60M	13D	Aug 21, 2026 ↗
Ami Sagy	12.90%	1.64M	13D	Nov 28, 2025 ↗

CollPlant Biotechnologies (ADR)

Breakdown13F · 13D/G · Form 4

Top shareholders13F · 13D/G · Form 4

Institutions13F, as of Mar 31, 2026

Ownership statements13D/G · 5% or more, as filed

Insider tradesForm 4

Latest trades

CongressHouse and Senate disclosures